Skip to content

The value of fospropofol disodium in induction and maintenance of general anesthesia for patients undergoing ureteroscopy lithotripsy

The value of fospropofol disodium in induction and maintenance of general anesthesia for patients undergoing ureteroscopy lithotripsy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115044
Enrollment
Unknown
Registered
2025-12-22
Start date
2025-12-22
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney stone

Interventions

Fospropofol disodium group:Fospropofol disodium

Sponsors

The Second Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Body Mass Index (BMI) 18 - 30 kg/m^2; 2. Age 20 - 70 years old; 3. American Society of Anesthesiologists (ASA) classification I or II.

Exclusion criteria

Exclusion criteria: 1. Allergic to propofol or other anesthetic drug components; 2. Poorly controlled or untreated hypertension (resting blood pressure > 180/100 mmHg); 3. Having neurological or mental disorders that make cooperation impossible; 4. Accompanied by severe infection or severe functional abnormalities of important target organs; 5. Long-term use of analgesic and sedative drugs; 6.Use drugs that affect hemodynamics (such as alpha receptor blockers) 24 hours before the operation; 7. Expected difficult airway.

Design outcomes

Primary

MeasureTime frame
The success rate of sedation and the onset time of sedation effect;

Secondary

MeasureTime frame
Hemodynamic indicators;Perioperative indicators;Adverse reaction;

Countries

China

Contacts

Public ContactSui Hongyuan

The Second Hospital of Jiaxing

sui_hongyuan@163.com+86 415 517 9087

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026